Colorectal cancer and immunotherapy

Through immunotherapy, a person's immune system is supported in finding and killing cancer cells more efficiently. Immunotherapy may help patients with advanced Colorectal cancer (CR). Immunotherapy has changed the course of several cancers with dismal prognoses in the past, including advanced lung, melanoma, bladder, head, neck and tumours. Immunotherapy has shown significant promise in recent years for subsets of Colorectal Cancer (CRC) with Microsatellite Instability (MSI), for which newer therapies such Programmed Death-1 (PD-1) inhibitors are beneficial. All CRC patients may benefit from these immunotherapeutics, even though other immunotherapeutics are still in the early stages of development.